Arbutus Reports Second Quarter 2021 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Arbutus Biopharma (ABUS) Misses Q2 EPS by 1c
August 5, 2021 7:51 AM EDTArbutus Biopharma (NASDAQ: ABUS) reported Q2 EPS of ($0.23), $0.01 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $2.33 million versus the consensus estimate of $2.12 million.
For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.
... More